A new antitumor antibiotic vicenistatin was isolated from the culture broth of Streptomyces sp. HC34. The structure of vicenistatin was elucidated by NMRspectral analysis. Vicenistatin exhibited antitumor activity against humancolon carcinoma Co-3 in the xenograft model.
In the couse of screening for new antitumor antibiotics, Streptomyces sp. HC34was found to produce a novel antitumor antibiotic vicenistatin. Vicenistatin was recovered from the mycelium cake with acetone extraction and purified by chromatography. Structural studies revealed it to possess a novel 20-membered macrocyclic lactam ring and a novel amino sugar.
Vicenistatin showedgrowth inhibition against various tumor cells in vitro, and also showedantitumor activity against humancolon carcinoma Co-3 in the xenograft model.
In this paper, we describe the production, isolation, structural elucidation and biological properties of vicenistatin.
Taxonomy of the Producing Strain
Culture HC34 was isolated from a soil sample collected at Kiryu, Gunma Prefecture, Japan.
Characterization of the strain was carried out mainly by the methods described by Shirling and Gottlieb1}. The aerial mycelium of the strain monopodially branched on the long main stem and terminated in spirals forming spore chains with 10~50 spores per chain. The spores were cylindrical or oval (0.5~0.7 x 0.7~1.6/mi) with smooth surfaces. The cultural and physiological properties of strain HC34 grown on various media at 27°C are shown in Tables 1 and 2 , respectively. The whole-cell hydrolysate contained the l,l isomer of diaminopimelic acid which corresponds to cell-wall type 1. Based on these morphological and chemotaxonomic characteristics, it was concluded that the strain belongs to the genus Strep tomyces.
Fermentation
A well grown agar slant of Streptomyces sp. HC34was used to inoculate a 500-ml Erlenmeyer flask containing 100ml of fermentation medium consisting of potato starch 3%, soya flake 1.5%, yeast extract 0.2%, corn steep liquor 0.5%, NaCl 0.3%, MgS<V7H2O 0.05%, CoCl2-6H2O 0.0005% and CaCO3 0.3%, the pH being adjusted to 7.1 before sterilization. The fermentation was carried out at 27°C for 3 days with shaking on a rotary shaker. A 600ml portion of the culture was inoculated into 50-liter jar fermenter containing 30 liters of a production medium having the same composition as the flask fermentation medium. The fermentation was run at 27°C for 5 days with agitation at 400rpm and aeration rate of 30 liters per minute.
Isolation and Purification
The fermentation broth (60 liters) was centrifuged to give a mycelium cake. The mycelium cake was extracted with acetone (20 liters). The extract was filtered and concentrated in vacuo to an aqueous solution. The solution was extracted twice with 5 liters of ethyl acetate at pH10. After evaporation, the residue was applied to a silica gel column (Wakogel, C-200, 12x 30cm) which was developed with chloroform -methanol (10 : 1). The active eluate was concentrated to dryness and then subjected to Sephadex LH-20 chromatography (3.5 x 50cm) with chloroform-methanol (1 : 1). The active fractions were concentrated to dryness to give a colorless powder of vicenistatin (950mg).
Structural Elucidation
The physico-chemical properties of vicenistatin (1) were summarized in Table 3 . The molecular formula of 1 was established as C30H48O4N2on the basis of HRFAB-MS data. In the IR spectrum, 1 showed strong bands at 3400 (OH and/or NH) and 1655 cm" 1 (amide). The *H NMR spectrum taken in pyridine-d5 (Fig. 2) Detailed analysis of the 1H-1HCOSYand the decoupling experiments proved the partial structures A, B and C as shown in Fig. 3 . And the remaining carbons of 1 were two singlet methyls (C-21, 3 18.0 and C-22, 3 17.3), one NCH3 (C-7, 3 34.0), one isolated methylene (C-ll, 3 49.5) and one amide carbonyl carbon (C-l, 3 166.4). Further structural elucidation was performed by the observations of the long range And the presence of 20-membered macrocyclic lactam moiety in 1 was established (Fig.  4 ).
In the partial structure C, NOEwas observed between l' -H and 5' -H (Fig. 4) . Therefore, the partial structure C was confirmed to constitute a hexopyranose. And the long range coupling of l'-H (anomeric proton) to C-7 (5 85.9) in the HMBC experiment showed the linkage of this hexopyranose to the macrocyclic lactam ring at C-7. A NCH3 group located at C-4' (S 65.3) was also proved by the observation of long range coupling in the HMBC experiment (Fig. 4) . The relative stereochemistry for this amino sugar was determined by the coupling constants. Large coupling constants ot JVt2'ax= 9.5 Hz and /4%5,=9.8 Hz indicated that l'-H, 4'-H and 5'-H were axially oriented. 3'-H was determined to be the equatorial orientation because of its small coupling constants (/2 ax 3 =2.8 Hz, /2 eq 3 =4.2Hz and /3, 4, = 3.0 Hz). Methanolysis of 1 yielded a methyl j?-glycoside (2). The absolute configuration of 2 was determined by TACu method3). The negative contribution (^[M]435(TACu) -872°) of 2 suggested that this sugar belonged to the D-series (Table 5) . Therefore, the structure of this amino sugar was established to be 4-methylamino-2,4,6-trideoxy-/?-D-ribohexopyranose.
As far as we know, this amino sugar was found for the first time and the name vicenisamine was given. From all these findings, the total structure of 1 was deduced as shown in Fig. 1 .
The geometries of C-2, C-4 and C-14 were proved to be all E by the coupling constants of /2,3=15.0Hz, 74,5=15.5Hz and /14?15=15.0Hz, respectively. Up field chemical shifts of C-21 (S 1 8.0) and C-22 (S 17.3) and no NOEs between 9-H and 21-H, and 13-H and 22-H showed E configurations for C-10 and C-12. The cis relation between 20-CH3 and 7-H was established based on NOEnetworks as shown in Fig. 4 and a large coupling constant (/6 7=9.0Hz), but the stereochemistry at C-18
remains to be determined.
Someother macrocyclic lactam antibiotics are JULY 1993 Tumorfragment of Co-3 was implanted sc into 6~8-week-old female nude mice (BALB/c nu/nu Sic) and when tumor size reached 100~300 mm3, vicenistatin or mitomycin was given iv. From the start of the treatment, tumor growth inhibition rate (TGIR) of each compoundwas calculated for 3 weeks as follows; TGIR=(1-mean tumor volume of treatment group/ mean tumor volume of control group) x 100. a MaximumTGIR value through 3 weeks. known such as hitachimycin4), fluvirucins5) and BE-141066). Especially, BE-14106 also possess a 20-membered macrocyclic lactam ring. However, 1 is different from BE-14106 in the point that 1 contains a novel amino sugar (vicenisamine). Biological Activity 1 was tested for its in vitro cytotoxicity.
IC50 Og/ml) values against HL-60 (human leukemia) and COLO205(human colon carcinoma) were 0. 12 and 0. 19, respectively. Additionally, the antitumor activity of 1 was determined in Co-3 (human colon carcinoma) implanted nude mice7). The results are shown in Table 6 . 1 exhibited antitumor activity against Co-3. The unique structural feature of 1 makes it an interesting lead compound for antitumor agents. Further biological studies are in progress. Experimental General Specific rotation was obtained on a Jasco DIP-140 spectropolarimeter. Mass spectra were measured on a JEOLJMS-SX102Ain the FABmode using glycerol matrix. UVand IR spectra were recorded on a Hitachi U-3200 spectrophotometer and a Jasco A-3 spectrophotometer, respectively. NMRspectra were obtained on a JEOLJNM-GX500spectrophotometer with XHNMRat 500 MHzand 13C NMRat 125 MHz. Chemical shifts are given in ppm using TMSas internal standard.
Methanoiysis of 1 A solution of 50mg of 1 in 10ml of 5% HCl-MeOHwas boiled under reflux for 40minutes. The solution was concentrated, and the residue was chromatographed on a silica gel using chroloform -methanol (5 : 1). The eluate was concentrated to yield 9.2mg of methyl /?-D-vicenisaminide (2). Physico-chemical properties of 2: see Table 5 .
